Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
Open-market buys, last 90 days
$29,501
in 3 filings
Open-market sales, last 90 days
$27,505
in 1 filing, $28K under 10b5-1 plans

Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 39 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-02 Amoroso Michael President and CEO Option exercise 10b5-1 +283,390 352,128
2023-11-02 Amoroso Michael President and CEO Option exercise · Restricted Stock Units 10b5-1 −283,390 566,610
2023-11-02 Kelly John Alexander Chief Financial Officer Option exercise +108,188 497,479
2023-11-02 Kelly John Alexander Chief Financial Officer Option exercise · Restricted Stock Units −108,188 216,312
2023-08-31 Scimeca Dario General Counsel and Secretary Grant or award +5,443 $0.39 $2K 73,916
2023-08-31 SMITH J. JEFFERSON Chief Research Officer Grant or award +5,175 $0.39 $2K 1,940,254
2023-08-31 Kelly John Alexander Chief Financial Officer Grant or award +5,951 $0.39 $2K 389,291
2023-08-18 Kelly John Alexander Chief Financial Officer Purchase +90,000 $0.48 $43K 383,340
2023-08-18 Kelly John Alexander Chief Financial Officer Grant or award +90,000 $0.48 $43K 383,340
2023-06-08 Scimeca Dario General Counsel and Secretary Sale 10b5-1 −13,361 $0.75 $10K 68,473
2023-06-07 Barton Shane VP & Corporate Controller Option exercise +6,060 27,502
2023-06-07 Barton Shane VP & Corporate Controller Option exercise · Restricted Stock Units −6,060 6,060
2023-06-07 Kelly John Alexander Chief Financial Officer Option exercise +34,091 279,705
2023-06-07 Kelly John Alexander Chief Financial Officer Option exercise +13,635 293,340
2023-06-07 Kelly John Alexander Chief Financial Officer Option exercise · Restricted Stock Units −34,091 0
2023-06-07 Kelly John Alexander Chief Financial Officer Option exercise · Restricted Stock Units −13,635 13,635
2023-06-07 SMITH J. JEFFERSON Chief Research Officer Option exercise +4,872 1,935,079
2023-06-07 SMITH J. JEFFERSON Chief Research Officer Option exercise · Restricted Stock Units −4,872 4,872
2023-06-07 Scimeca Dario General Counsel and Secretary Option exercise 10b5-1 +22,727 72,790
2023-06-07 Scimeca Dario General Counsel and Secretary Option exercise 10b5-1 +9,044 81,834

Page 12 of 23 · 456 trades